Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. biopharma to participate in panel discussion on investment opportunities in china hosted by duane morris and the chinese biopharmaceutical
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Magazines
Events
Downloads
Videos

Refine by
Date

  • This month
  • This Year
  • Older

Biopharma To Participate In Panel Discussion On Investment Opportunities In China Hosted By Duane Morris And The Chinese Biopharmaceutical Articles & Analysis

847 news found

Sale of 0.025-0.08mm 8011 / 8021 / 8079 O-temper Cold Forming Aluminum Foil for Pharmaceutical Packaging

Sale of 0.025-0.08mm 8011 / 8021 / 8079 O-temper Cold Forming Aluminum Foil for Pharmaceutical Packaging

What is Cold Forming Aluminum Foil? Cold forming aluminum foil is a high-barrier laminated material used in pharmaceutical packaging. It is composed of multiple layers of different films through a lamination process, with the core layer being O-temper (soft) aluminum foil. This structure provides excellent deep-drawing performance. Structure of Cold Forming Aluminum Foil A typical cold forming ...

ByHenan Hongchang Aluminum Co., Ltd.


Advanced Instruments’ acquisition of Nova Biomedical completed

Advanced Instruments’ acquisition of Nova Biomedical completed

Following regulatory approval, Advanced Instruments, a wholly-owned subsidiary within Patricia Industries, has now completed its acquisition of Nova Biomedical, a global provider of analytical instruments and consumables for the biopharmaceutical and clinical markets. The enterprise value amounts to USD 2.2bn. Patricia Industries has contributed USD 1.6bn in financing. The remainder of the ...

ByArtel, Inc. by Advanced Instruments


Creative Diagnostics Launches Human Hybrid IgM Control Monoclonal Antibodies to Accelerate Diagnostic Assay Development

Creative Diagnostics Launches Human Hybrid IgM Control Monoclonal Antibodies to Accelerate Diagnostic Assay Development

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced release of its new line of Human Hybrid IgM Control Monoclonal Antibodies for research applications, covering a range of diseases such as CMV, HSV, MeV, MuV, RuV, and VZV.Characteristic disease state sera are serum samples derived from individuals with specific conditions or diseases. ...

ByCreative Diagnostics


Biopharma PEG Achieves FDA DMF Approval for HZ-PEG-HZ

Biopharma PEG Achieves FDA DMF Approval for HZ-PEG-HZ

Watertown, MA - June 29, 2025 - Biopharma PEG, a leading innovator in high-quality polyethylene glycol (PEG) derivatives, today announced it has successfully obtained Drug Master File (DMF) approval from the U.S. Food and Drug Administration (FDA) for its self-developed HZ-PEG-HZ (1K) product. The assigned DMF number is 041864. This significant achievement underscores Biopharma PEG's robust ...

ByBiopharma PEG Scientific Inc


Huateng Pharma Highlights the Pharmaceutical Potential of N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7)

Huateng Pharma Highlights the Pharmaceutical Potential of N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7)

Versatile compound shows promise in drug synthesis, metal chelation, antioxidant activity, and moreChangsha, China – May 22, 2025– Hunan Huateng Pharmaceutical Co., Ltd., a leading global supplier of PEG derivatives and pharmaceutical intermediates, is proud to offer high-purity N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7) to researchers and pharmaceutical developers worldwide. This ...

ByHunan Huateng Pharmaceutical Co. Ltd.


Creative Diagnostics Expands Hepatitis B Research Tools with High Performance HBV Surface Antigen L-Proteins

Creative Diagnostics Expands Hepatitis B Research Tools with High Performance HBV Surface Antigen L-Proteins

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced the expansion of its Hepatitis B research portfolio with a comprehensive range of sensitive and specific Hepatitis B Virus Surface Antigen L-proteins. These rigorously validated antigens are suitable for use in HBV mimetics, standard antigens for ELISA, and Western blotting, and are ...

ByCreative Diagnostics


Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee

Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee

Kalaris Therapeutics, Inc. (Nasdaq: KLRS) (“Kalaris”), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, today announced the appointment of Leone Patterson to its Board of Directors and as Chair of the Board’s Audit Committee. “We’re delighted to welcome Leone as Chair of the ...

ByKalaris


Huateng Pharma to Showcase Extensive PEG Derivatives and CDMO Capabilities at CPHI Japan 2025

Huateng Pharma to Showcase Extensive PEG Derivatives and CDMO Capabilities at CPHI Japan 2025

Changsha, China – 18 March 2025 – Hunan Huateng Pharmaceutical Co., Ltd., a global leader in PEG derivatives and CDMO services for APIs and intermediates, is pleased to announce its participation in CPHI Japan 2025. The company will exhibit its comprehensive product lines and cutting-edge capabilities at Booth No. 4X-06, located at Tokyo Big Sight, Tokyo, Japan, from April 9th to ...

ByHunan Huateng Pharmaceutical Co. Ltd.


Advanced Instruments to acquire and merge with Nova Biomedical

Advanced Instruments to acquire and merge with Nova Biomedical

Patricia Industries’ subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, today announced the execution of a definitive agreement to acquire Nova Biomedical, a manufacturer of innovative analytical instruments and consumables that are vital in guiding the treatment of patients and the development of biotechnology ...

ByAdvanced Instruments


Biopharma PEG Announces FDA DMF Registration for mPEG-pALD (20K)

Biopharma PEG Announces FDA DMF Registration for mPEG-pALD (20K)

Biopharma PEG, a leading manufacturer of high-quality polyethylene glycol (PEG) derivatives, today announced that its mPEG-pAld (20K) product has successfully achieved DMF (Drug Master File) registration with the U.S. Food and Drug Administration (FDA) under DMF number 040600. “We are thrilled to receive FDA DMF registration for our mPEG-pAld (20K) product,” said Sonia Lee, Marketing ...

ByBiopharma PEG Scientific Inc


CD Bioparticles Announces Enhanced Online Ordering System for Improved Customer Experience

CD Bioparticles Announces Enhanced Online Ordering System for Improved Customer Experience

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, recently unveiled its significantly enhanced online ordering system. This latest update on the website aims to streamline the ordering process for customers, demonstrating CD Bioparticles' commitment that prioritize customer experience, while also creating greater workflow control, making it more ...

ByCD Bioparticles


SOPHiA Genetics Achieves ISO 27017 and ISO 27018 Certifications

SOPHiA Genetics Achieves ISO 27017 and ISO 27018 Certifications

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced it has successfully achieved ISO/IEC 27017:2015 and ISO/IEC 27018:2019 certifications for information security and privacy protection in its cloud services from BSI, the business improvement and standards company. It has also achieved recertification to ISO/IEC ...

BySOPHiA Genetics


Protheragen Announces Vaccine Development Services Targeting Rare Infectious Diseases

Protheragen Announces Vaccine Development Services Targeting Rare Infectious Diseases

Protheragen is proud to release the launch of its comprehensive vaccine development solutions tailored to advance research and development in the field of infectious diseases. This strategic initiative aims to accelerate the creation of effective vaccines to combat emerging and re-emerging infectious threats. Infectious diseases are disorders caused by organisms — such as bacteria, ...

ByProtheragen


Biopharma PEG Offers 30% Thanksgiving Discount on Monodispersed PEGs

Biopharma PEG Offers 30% Thanksgiving Discount on Monodispersed PEGs

Watertown, MA — November 25, 2024—In the spirit of Thanksgiving, Biopharma PEG Scientific Inc. would like to express its sincere gratitude to our esteemed customers and partners for their trust and support. It is a privilege to collaborate with you, and we look forward to further strengthening our partnership in the future.As a gesture of our appreciation, we are pleased to announce a 30% ...

ByBiopharma PEG Scientific Inc


Protheragen-ING Announces Lyophilized Flash-release Formulations Development Capabilities

Protheragen-ING Announces Lyophilized Flash-release Formulations Development Capabilities

Protheragen-ING has recently announced its ability to provide freeze-drying flash-release formulation development services to clients involved in drug discovery and development worldwide. Lyophilized flash-release formulations are advanced drug delivery systems that incorporate the benefits of both lyophilization and flash-release technologies. “Whether customers are trying to develop a ...

ByProtheragen-ING


SOPHiA GENETICS Announces Expanded Partnership with Tennessee Oncology

SOPHiA GENETICS Announces Expanded Partnership with Tennessee Oncology

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, announced today that Tennessee Oncology, one of the United States’ largest community-based cancer care specialists that treats nearly half of Tennessee’s cancer patients across 35 clinics, has expanded its relationship with SOPHiA GENETICS to advance its cancer research. ...

BySOPHiA Genetics


SOPHiA GENETICS and Genomenon Collaborate to Streamline Genetic Research

SOPHiA GENETICS and Genomenon Collaborate to Streamline Genetic Research

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, today announced the next step in the partnership between the Company and Genomenon, a leading genomic intelligence company, to support better, data-driven outcomes in the rare disease and oncology fields. The two companies have expanded the integration of Genomenon’s Mastermind® Genomic ...

BySOPHiA Genetics


H5N1 Antibodies and Antigens for Research Applications

H5N1 Antibodies and Antigens for Research Applications

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, is excited to announce the launch of its new line of H5N1 Antibodies and Antigens to support cutting-edge research on this highly pathogenic influenza A virus subtype. These innovative products offer researchers and scientists invaluable tools for studying and combating the H5N1 influenza virus. ...

ByCreative Diagnostics


Huateng Pharma: Empowering ADC Development with Premium Monodispersed PEGs

Huateng Pharma: Empowering ADC Development with Premium Monodispersed PEGs

Changsha, China – Hunan Huateng Pharmaceutical Co., Ltd. is proud to provide high-quality monodispersed polyethylene glycols (PEGs) tailored for the evolving needs of antibody-drug conjugates (ADCs). With the ADC market surpassing $10 billion in 2023 and projected to reach $13.13 billion by 2030, our commitment to innovation and quality is stronger than ever. Among the 15 approved ADCs ...

ByHunan Huateng Pharmaceutical Co. Ltd.


Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy

Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy

Watertown, MA — October 24, 2024 — Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development is more critical ...

ByBiopharma PEG Scientific Inc

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT